SCHEMBL16401264

SCHEMBL16401264

NC1CCN(C(=O)O)C(c2ccccc2)C1

nearest known ligand 0.49

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 7/20 0.49
KDM1A O60341 1/20 0.41
MAOA P21397 1/20 0.41
SMYD3 Q9H7B4 1/20 0.41
POLB P06746 1/20 0.40
TACR1 P25103 1/20 0.40
HSD11B1 P28845 1/20 0.39
BACE1 P56817 1/20 0.39
CFB P00751 1/20 0.39
HSP90AA1 P07900 1/20 0.38
HSP90AB1 P08238 1/20 0.38
PRMT5 O14744 2/20 0.38
WDR77 Q9BQA1 2/20 0.38
KDM4E B2RXH2 1/20 0.38
MAPT P10636 1/20 0.38
HPGD P15428 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20449214 0.85 RIPK1 (0.50) RIPK1POLBHSD11B1BACE1HSP90AA1
SCHEMBL20449170 0.85 RIPK1 (0.50) RIPK1POLBHSD11B1BACE1HSP90AA1
SCHEMBL29116156 0.84 RIPK1 (0.49) RIPK1MAOATACR1
SCHEMBL29891706 0.84 RIPK1 (0.54) RIPK1KDM1ASMYD3TACR1
SCHEMBL29891698 0.83 RIPK1 (0.46) RIPK1KDM1AMAOAPOLBHSD11B1
SCHEMBL17026995 0.83 RIPK1 (0.67) RIPK1POLBHSD11B1HSP90AA1HSP90AB1
SCHEMBL16401399 0.82 RIPK1 (0.50) RIPK1POLBHSD11B1BACE1CFB
SCHEMBL30668564 0.81 PRMT5 (0.54) RIPK1POLBHSD11B1BACE1PRMT5
SCHEMBL580929 0.81 AKR1C3 (0.51) RIPK1POLB
SCHEMBL17782223 0.81 RIPK1 (0.50) RIPK1KDM1AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104955824-B It is used as the aminopyrimidine compounds of the inhibitor of the EGFR mutant containing T790M 豪夫迈·罗氏有限公司 2017-09-22 CN disclosed
EP-3022192-A1 PIPERIDINYL INDOLE DERIVATIVES AND THEIR USE AS COMPLEMENT FACTOR B INHIBITORS Novartis AG (CH) 2016-05-25 EP disclosed
WO-2015009616-A1 PIPERIDINYL INDOLE DERIVATIVES AND THEIR USE AS COMPLEMENT FACTOR B INHIBITORS NOVARTIS AG (CH) 2015-01-22 WO disclosed